Search results
J INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing...
Benzinga· 5 days agoJ INTS BIO provided an update of its ongoing Phase 1 clinical study of JIN-A02, a 4th generation EGFR-TKI for NSCLC treatment, during the 3rd of June poster session of the 2024 American Society ...
Obsidian’s Avowed Gets New Story Trailer, Still No Release Date - Xbox Games Showcase 2024 - IGN
IGN Videogames· 5 days ago"Explore the Living Lands, a mysterious island filled with adventure and danger," Avowed's story...
Obsidian’s Avowed Gets New Story Trailer, Still No Release Date - Xbox Games Showcase 2024
IGN Videogames· 5 days ago"Explore the Living Lands, a mysterious island filled with adventure and danger," Avowed's story...
How Cinnamon Can Benefit Your Health
Mercola· 3 days agoMaharishi Ayurveda Products International (MAPI) notes that cinnamon is often used for Ayurvedic recipes to enhance the bioavailability of other herbs while combining a delicious mixture of ...
ASCO: AffyImmune builds up foundations of autologous CAR T cell therapy
BioPharma-Reporter· 3 days agoThe US firm AffyImmune Therapeutics discusses how its donor cell-derived candidate could address...
Dominari Holdings Inc. (NASDAQ:DOMH) Short Interest Up 191.7% in May
ETF DAILY NEWS· 2 days agoDominari Holdings Inc. (NASDAQ:DOMH – Get Free Report) was the target of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 3,500 ...
Ruvidar(TM) Enhances Efficacy of Cancer Drug
The Joplin Globe· 4 days agoTORONTO, ON / ACCESSWIRE / June 10, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
Ruvidar(TM) Enhances Efficacy of Cancer Drug
Digital Journal· 4 days agoTORONTO, ON / ACCESSWIRE / June 10, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoJ INTS BIO, ASCO 2024 - JIN-A02 showed tumor reductions including brain metastasis in the ongoing first-in-human, dose-finding Phase 1 clinical study PR Newswire SEOUL, South Korea, June 10, 2024 SEOUL, South Korea, June 10, 2024 /PRNewswire/ --
